Incyte-Lilly drug that skin disease drug fared well in Phase 3 trial

Delaware Business Now

Aug 27, 2019

Eli Lilly and Company and Incyte Corporation announced that a drug used to treat a type of skin disease is doing well in a late-stage trial. The BREEZE-AD7 trial is slated for comp…